Stephane De Botton

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (9)

Martin Figeac

Université de Lille

FRANCE

View details

Mark J. Levis

Johns Hopkins University

UNITED STATES

View details

Hans Beier Ommen

DENMARK

View details

Harry P. Erba

UNITED STATES

View details

Hee-Je Kim

Professor

SOUTH KOREA

View details

Richard Larson

Professor

University of Chicago

UNITED STATES

View details

Courtney D. DiNardo

UNITED STATES

View details

Pau Montesinos

SPAIN

View details

Paresh Vyas

University of Oxford

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Stephane De Botton

Research Interests

Explore related searches

Contact this professor

Articles (11)

Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial

LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study.

When monoclonal gammopathy‐associated chronic neutrophilic leukemia is a reactive process distinct from a clonal myeloproliferative neoplasm: Lessons from mistakes

Safety, efficacy, and PK/PD of vorasidenib in previously treated patients with mIDH1/2 hematologic malignancies: A phase 1 study

Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML

Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML

Improved survival with enasidenib versus standard of care in relapsed/refractory acute myeloid leukemia associated with IDH2 mutations using historical data and propensity score matching analysis

Differentiation syndrome with lower‐intensity treatments for acute myeloid leukemia

A personalized approach to guide allogeneic stem cell transplantation in younger adults with acute myeloid leukemia

Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML

Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia

Collaborators (9)

Martin Figeac

Mark J. Levis

Hans Beier Ommen

Harry P. Erba

Hee-Je Kim

Richard Larson

Courtney D. DiNardo

Pau Montesinos

Paresh Vyas

Make your next move.